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DISSERTATION ABSTRACT 
 
Jeneva Koryn Anderson 
 
Doctor of Philosophy 
 
Department of Chemistry and Biochemistry 
 
March 2015 
 
Title: Characterization of Helicobacter pylori AutoInducer-2 Binding Proteins Involved 
in Chemorepulsion and Biofilm Dispersal 
 
 
Helicobacter pylori is a human pathogen that colonizes the stomach and increases the 
risk of diseases such as ulcers and gastric cancer. The distribution of H. pylori within the 
stomach is associated with different disease outcomes, with more dispersed colonization 
correlated with gastric cancer. The focus of this research is to study the chemotactic 
responses that promote dispersal of H. pylori within the stomach. We have shown 
previously that H. pylori perceive the quorum signal autoinducer-2 (AI-2) as a 
chemorepellent. We report that H. pylori chemorepulsion from endogenous AI-2 influences 
the proportion and spatial organization of cells within biofilms. Strains that fail to produce 
AI-2 (∆luxS) or are defective for chemotaxis (∆cheA) formed more spatially homogenous 
biofilms with a greater proportion of adherent versus planktonic cells than wildtype 
biofilms. Reciprocally, a strain that overproduced AI-2 (luxSOP) formed biofilms with 
proportionally fewer adherent cells. Along with the known AI-2 chemoreceptor, TlpB, we 
identified and characterized two novel periplasmic binding proteins, AibA and AibB, that 
independently both bind AI-2 and are required for the AI-2 chemorepulsion response. 
Disruptions in any of the proteins required for AI-2 chemotaxis recapitulated the biofilm 
adherence and spatial organization phenotype of the ∆luxS mutant. Furthermore, 
exogenously administered AI-2 was sufficient to decrease the proportion of adherent cells 
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in biofilms and promote dispersal of cells from biofilms in a chemotaxis dependent 
manner. Finally, we found that disruption of AI-2 production or AI-2 chemotaxis resulted 
in increased clustering of cells in microcolonies on cultured epithelial cells. We conclude 
that chemotaxis from AI-2 is a determinant of H. pylori biofilm spatial organization and 
dispersal and may play an important role in H. pylori colonization of the stomach by 
promoting dispersal away from areas of high cell density, thereby modulating the disease 
spectrum of the host. 
 
This dissertation contains previously unpublished, co-authored material.
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CHAPTER I 
INTRODUCTION 
 Helicobacter pylori is a Gram-negative bacterium that resides in the human 
stomach. The prevalence of H. pylori infection is approximately 50% worldwide, with 
higher infection incidences in developing countries (1). Chronic infection with H. pylori 
is linked to various gastroduodenal diseases, including chronic inflammation, peptic 
ulcers, and in the most severe cases gastric adenocarcinoma and mucosa-associated 
lymphoid tissue lymphoma (2, 3). The majority of patients infected with H. pylori remain 
largely asymptomatic, but in approximately 10-15% of cases, patients develop peptic 
ulcers, and in approximately 1% of cases will develop gastric cancer (4). However as of 
2012, stomach cancer still remains as the third leading cause of cancer related deaths in 
both sexes worldwide (5, 6). Thus, much research has been focused on studying H. pylori 
biology and determining effective treatment strategies. The current therapeutic strategy is 
to treat the infection with a proton pump inhibitor and antibiotics such as clarithromycin, 
amoxicillin and/or metronidazole (7). However, worldwide increasing levels of 
antibiotic-resistant H. pylori are contributing to failure in treatment of H. pylori infection 
(7). Current research is focusing on alternative strategies to target H. pylori to treat the 
infection before the development of disease in patients. 
 
Mechanisms of H. pylori in Promoting Gastric Disease 
 H. pylori has several known virulence factors that affect host pathways and 
promote disease states. The most well studied toxins are the virulence proteins CagA and 
VacA (3). The Cytotoxin-Associated Gene A (CagA) is found in ~70% of H. pylori 
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strains worldwide (3). The cagA gene encodes for the CagA protein that is injected by the 
type-IV secretion system directly into host epithelial cells (8). Once inside the host cells, 
CagA is able to interact with several host processes, including promoting cell 
proliferation, differentiation, induction of inflammatory responses, and influence on cell 
polarity and tight junctions (3, 8). Thus, it is thought that CagA is able to induce 
abnormalities and overproliferation of cells in the gastric epithelium that are consistent 
with cancer. The cagA gene is highly prevalent in strains of H. pylori isolated from 
patients who are symptomatic for gastric disease; patients with gastric cancer are twice as 
likely to be infected with a strain of H. pylori that carries the cagA gene than a cagA 
negative strain (9, 10). Thus, the ability of H. pylori to inject this virulence protein into 
host epithelial cells plays an important role in development of disease in the patient. 
 The Vacuolating Cytotoxin A (VacA) protein is also highly correlated in strains 
of H. pylori causing disease in patients (11, 12). Receptors on a variety of host epithelial 
cells are able to bind to VacA, which can influence several cellular processes including 
pro-inflammatory signaling (11). VacA has also been shown to act intracellularly in host 
epithelial cells to promote apoptosis, induce vacuole formation inside host cells, alter 
immune responses, and disrupt cellular pathways including transcriptional regulation (3). 
Many of these pathways are contributing factors for development of gastric disease. 
Among the many commonalities between CagA and VacA, one of the most important is 
that the proteins need to get inside host cells in order to influence the host pathways that 
contribute to disease. To do so, H. pylori needs to be able to establish and persist in the 
highly acidic organ of the stomach to expose the host epithelial cells to these disease 
associated proteins. 
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H. pylori Persistence in the Human Stomach 
 The chemical environment of H. pylori’s preferable niche is one that many other 
bacteria cannot tolerate. The stomach is the least colonized region of the gastrointestinal 
tract, being colonized with 101-103 CFU/g bacteria (13). It is thought that the high acidity 
of the organ prevents persistent colonization of most types of bacteria. Within the 
stomach, there is a gradient of acid that is generated with the highest acidity (pH < 2) in 
the lumen of the organ, and the least acidity (pH ~ 7) near the epithelial cells (14). A 
unique feature of H. pylori is the production of urease by the cell that is able to neutralize 
its immediate environment. This allows survival of the cell in the acidic lumen and gives 
the opportunity for the cell to navigate to its preferred niche of the more neutral pH of the 
stomach epithelial lining (15), which is perhaps what gives this bacteria an advantage in 
this sparsely colonized environment. 
The strategy of H. pylori to navigate to the neutral epithelial cells relies on the 
ability of the bacterial cell to direct its movement down the proton gradient. To do this, 
H. pylori use a system called chemotaxis to detect and respond to chemicals in the 
environment. Chemotaxis is a signaling process employed by bacteria to respond to 
changes in the chemical environment by altering swimming behaviors to swim towards 
attractive chemicals (chemoattractants) and away from repulsive chemicals 
(chemorepellents). This signaling system is characterized by a set of proteins that relay 
extracellular signals (chemoeffectors) to changes in the bacterial flageller motor that alter 
the rotation of the flagella and modulate swimming behaviors. Chemoeffectors bind to 
receptors (typically Methylaccepting-Chemotaxis Proteins, MCPs) that are 
transmembrane receptors. A conserved set of Che proteins reside intracellularly that are 
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responsible for relaying chemoeffector-receptor binding events to the flagellar motor. 
The protein CheW binds to the MCP receptor, which in turn allows binding of the 
histidine kinase CheA. Upon receiving a signal, CheA phosphorylates a cytoplasmic 
protein CheY; once phosphorylated, CheY can interact with proteins at the flagellar 
motor to switch the rotation of the flagella and alter the cell’s swimming behaviors. CheY 
quickly becomes dephosphorylated by a protein called CheZ, and loses the interaction 
with the flagaller motor until it is phosphorylated again by CheA upon a subsequent 
signaling event. (16) This phosphoregulation pathway allows the bacterial cell to be 
sensitive to changes in the extracellular chemical environment, and respond rapidly if 
conditions become unfavorable. H. pylori use this system to sense and respond to acid as 
a chemorepellant; thus, at high proton concentrations, H. pylori will orient its movement 
down the proton gradient until it moves into a more neutral location.  
Once at the neutral pH of the stomach epithelium, H. pylori colonize in the gastric 
glands in the antrum of the stomach (17). Normally, H. pylori will colonize within the 
gastric glands in dense communities described as microcolonies (18). This process has 
been demonstrated in murine models to be dependent on the ability of the H. pylori cells 
to chemotax; chemotactic null mutants are not found in the gastric glands, but instead 
colonize on top of the epithelial cell layer (19). Thus, chemotaxis plays an important role 
in guiding H. pylori to the neutral stomach epithelium, but also in the way H. pylori 
organize themselves within the stomach epithelium. These differences in spatial 
localization of H. pylori within the stomach are correlated with different disease 
outcomes in human patients with H. pylori infection. A more localized infection of H. 
pylori in the antrum of the stomach is correlated with peptic ulcer diseases, whereas a 
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more broadly distributed infection of H. pylori throughout other areas of the stomach is 
correlated with more severe gastric cancer disease (4). Thus, this motivates research into 
understanding the mechanisms that drive dispersal of H. pylori in its environment. 
Bacteria are able to respond chemotactically not only to host derived 
environmental cues (in the case of H. pylori, acid production by the host), but also to 
bacterially produced chemicals. H. pylori is known to respond to a self-produced 
quorum-sensing molecule called AutoInducer-2 (AI-2) (20). AI-2 is a small molecule 
produced by the enzyme LuxS as a by-product of the S-adenosyl-L-methionine pathway 
(21). Once produced, this molecule is secreted extracellularly into the environment, and 
is able to be sensed by bacteria, which can elicit a range of responses including 
chemotactic behaviors. AI-2 is an inter-species quorum-sensing molecule made and 
sensed by many different types of bacteria (22) that serves as readout of bacterial cell 
density. For H. pylori, AI-2 is perceived as a chemorepellant and will elicit avoidance-
swimming behaviors (20). The consequences of this chemorepellant response in H. pylori 
had not been explored in previous work, and the question remained what the role of AI-2 
chemorepulsion is in the spatial organization of H. pylori within its environment. 
In this dissertation, I will discuss my efforts to elucidate the function and 
mechanism of AI-2 chemotaxis in H. pylori. In the following chapter I will discuss my 
work using an in vitro biofilm assay to demonstrate the necessity of AI-2 chemotaxis in 
the spatial organization of H. pylori in biofilms, and the sufficiency of AI-2 to promote 
dispersal from biofilms in a chemotaxis dependent manner. From this work, I identified 
two novel proteins in H. pylori that are required for the AI-2 chemotaxis response, and 
discuss further characterization of these proteins in the following two chapters. Finally, I 
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will put my work into the larger context of H. pylori infection and treatment in the final 
discussion chapter of this dissertation. 
The following chapters II and III contain co-authored, unpublished material by 
myself and collaborators: Julie Huang (Amieva lab, Stanford University) and Dr. 
Christopher Wreden (Guillemin lab, University of Oregon) who performed the H. pylori 
microcolony assay and analysis in chapter II, and Dr. S. James Remington (University of 
Oregon) who performed the I-TASSER modeling of AibA and AibB proteins and 
proposed critical residues for AI-2 binding in chapter III. 
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CHAPTER II 
CHEMOREPULSION FROM THE QUORUM SIGNAL AUTOINDUCER-2 
PROMOTES HELICOBACTER PYLORI BIOFILM DISPERSAL 
 
This chapter contains co-authored material. Julie Huang (Amieva lab, Stanford 
University) performed the H. pylori microcolony infection assay (Figure 5) only. Dr. 
Christopher Wreden performed data analysis for lacunarity (Figure 1F, Figure 3H) and 
microcolony size (Figure 5B) only. 
 
Introduction 
In nature, bacteria often reside within multispecies aggregate communities called 
biofilms that serve to protect the cells from environmental challenges (23–27). Within 
these aggregated communities, bacterial cells secrete molecules that allow the biofilm to 
grow at environmental interfaces and attach to other cells and biotic or abiotic surfaces 
(28, 29). The persistence of biofilms on biotic surfaces, such as the lung epithelia of 
cystic fibrosis patients, or on abiotic surfaces, such as medical implants, poses serious 
human health risks (26, 30–32). Despite the medical importance of biofilm growth, many 
unanswered questions remain about the mechanisms that drive biofilm dynamics. 
 Biofilm formation is initiated by attachment of single cells to a surface, and these 
adherent cells grow as clonal populations into microcolonies. These microcolonies can 
further develop into mature biofilms with distinct cellular organization and structures 
(26). This process is dynamic, with continuous joining and leaving of cells in response to 
changes in the environment (28, 31). The biofilm lifecycle involves cellular processes 
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that occur over different time scales, and require long-term cell fate commitments as well 
as a need for bacterial cells to respond quickly to changes in the environment.  
 In many bacterial species, biofilm formation is influenced by quorum sensing, a 
mechanism bacteria use to coordinate their behavior (22, 33, 34). Quorum sensing 
involves the production of small molecules that are secreted into the environment and 
sensed by other bacterial cells in a population density dependent manner (22). Often the 
recipient bacteria respond to quorum sensing molecules by inducing changes in gene 
expression, such as those involved in long-term commitment to a sessile or planktonic 
lifestyle (22). For example, quorum sensing regulated genes are involved in the 
production of exopolysaccharides, lipids, nucleic acids, and proteases that are required to 
build the biofilm matrix (35–38).  
Quorum sensing can also elicit more immediate changes in bacterial behaviors by 
directing cellular motility through chemotactic responses. For example, in the predatory 
bacterial species Myxococcus xanthus, a secreted small molecule called A-factor alters 
motility and promotes aggregation and the initiation of fruiting body biofilm formation 
(39–41). Importantly for this study, the quorum sensing molecule AutoInducer-2 (AI-2), 
an interspecies quorum sensing molecule produced by the conserved metabolic enzyme 
LuxS, elicits chemotactic responses in multiple bacteria (20, 42). In the enteric 
commensal Escherichia coli, AI-2 elicits an attractant response (42), whereas in the 
gastric pathogen Helicobacter pylori, AI-2 is sensed as a repellant (20). In this study, we 
address how these rapid responses to quorum sensing molecules influence spatial 
distributions of cells within a biofilm community.  
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To explore this question, we studied the role of AI-2 chemotactic responses in H. 
pylori biofilm formation on abiotic and biotic surfaces. Previous work has shown that H. 
pylori form microcolonies and biofilms both in vitro on cultured epithelial cells as well as 
in vivo, as revealed in human stomach biopsies (18, 19, 43–47). Relevant to our study, 
Cole et al. showed that a luxS deficient H. pylori mutant exhibited increased levels of 
adherence to glass frit relative to a wild type strain (44). Here we replicate this finding 
and test whether it is due to loss of an endogenously produced chemorepulsive cue. We 
investigate the impacts of AI-2 production and sensing during early and late stages of 
biofilm growth and show that AI-2 chemotaxis is an important modulator of the 
equilibrium between planktonic and biofilm cells and the spatial distribution of cells 
within the biofilm. We define the molecular basis for AI-2 chemoreception in H. pylori, 
identifying two new periplasmic AI-2-binding binding proteins that are essential for this 
process. Additionally, we demonstrate that disruption of AI-2 production or AI-2 
chemotaxis results in increased microcolony size of H. pylori on cultured epithelial cells. 
Our work supports a novel mechanism whereby rapid chemotactic responses of 
individual cells to quorum sensing molecules contribute to the long-term spatial 
organization and aggregation properties of biofilms. 
 
Results 
AI-2 production and chemotaxis influence biofilm organization 
To investigate the importance of AI-2 chemorepulsion for H. pylori biology, we 
examined H. pylori biofilm organization as a function of AI-2 production. We spotted 
liquid cultures of G27 wild type (WT) and isogenic ∆luxS strains of H. pylori onto sterile 
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glass slides, which were cultured under static, humidifying microaerobic conditions for 
five days. The biofilms that formed at the air-liquid interface were fixed, stained with the 
DNA dye 4',6-diamidino-2-phenylindole (DAPI), and imaged using fluorescence 
microscopy (Fig. 1A-E). Upon visualization, it was immediately apparent that wild type 
and ∆luxS cells differed in their spatial distributions in biofilms. WT cells formed discrete 
multicellular aggregates, whereas the ∆luxS cells formed a homogeneous mat of cells 
(Fig. 1A,B). Genetic complementation of luxS (luxS*) was able to restore biofilm 
organization to the WT pattern (Fig. 1C). This result suggests that LuxS is required for 
normal multicellular organization within biofilms. We next wanted to test if increasing 
endogenous AI-2 production would alter the cellular organization in biofilms. We 
engineered a strain with an extra chromosomal copy of the luxS gene (luxSOP, over-
producer) expressed from the native luxS promoter and confirmed that this strain grew 
with similar kinetics to WT (Fig. A1A) and produced more AI-2 (Fig. A1B). Upon 
biofilm visualization, we observed that the luxSOP strain had cellular organization similar 
to that of WT (Fig. 1D).  
Fractal dimension and lacunarity have been used to quantify differences in spatial 
organization of biofilms (48, 49). Fractal dimension describes the complexity of the 
image while lacunarity measures the extent of discontinuities or inhomogeneity of the 
image (48). We used FracLac (an ImageJ plug-in) to calculate fractal dimension and 
lacunarity score for epifluorescence images of biofilms that were thresholded using 
contrast-limited adaptive histogram equalization (Fig. A2). Although we observed no 
difference in fractal dimension between any of the strains (data not shown), we did 
observe differences in lacunarity scores that correlate with perceived differences in the  
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Figure 1: Endogenous AI-2 production and chemotaxis alter biofilm 
organization. (A-E) Epifluorescence images of wild type and mutant G27 H. pylori 
biofilms grown on glass slides for 5 days. Cells were fixed and stained with DAPI 
(white). Scale bar is 100 μm. (F) Lacunarity scores for biofilm images. Each dot 
represents the lacunarity score of a single epifluorescence biofilm image post 
thresholding, with corresponding mean and standard deviation. (G) Schematic of glass 
frit biofilm assay with crystal violet analysis and example percent adherence calculation. 
(H) Effect of AI-2 production and chemotaxis on adherence of cells in biofilms on glass 
frit after five days, as quantified by the crystal violet assay. Error bars represent standard 
error of the mean for a minimum of three experiments for each strain. Daggers indicate a 
significant difference (p <0.05) from wild type using a Student’s T-test (F) or one-way 
analysis of variance (H). 
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images (Fig. 1F). ΔluxS had a significantly lower lacunarity score compared to WT, 
indicating more homogeneity. Reciprocally, the lacunarity score was significantly higher 
for luxSOP than WT, indicating more spatial inhomogeneity. We conclude that the spatial 
organization of cells in biofilms is dependent on levels of AI-2 production.The overall 
biofilm structure is the result of dynamic interactions of cells transitioning between 
sessile and planktonic states. We wished to quantify the fraction of the population in each 
of these states. To do so, we grew H. pylori cultures under static, microaerobic conditions 
in wells filled with glass frit to provide abundant surfaces for biofilm formation (Fig. 
1G). After two days, we used crystal violet staining to determine the proportion of 
adherent and planktonic cells for both WT and luxS derivatives (adapted from (44)) (Fig. 
1H). We observed that the ∆luxS strain had a significantly higher proportion of adherent 
cells as compared to WT and the luxS* strains. In addition, the luxSOP strain produced 
biofilms with a modest, but significant reduction in the proportion of adherent cells as 
compared to wild type biofilms. Together, these results suggest that normal biofilm 
formation and organization of H. pylori G27 are modulated by levels of endogenously 
produced AI-2. 
We hypothesized that the differences in biofilm organization we observed were 
due to chemorepulsion from endogenously produced AI-2. To test this, we investigated 
biofilm formation of a chemotaxis deficient strain, ∆cheA, which lacks the signal 
transduction protein CheA required for actuating chemotactic responses. The cellular 
organization of ∆cheA biofilms resembled those observed with the ∆luxS strain with 
uniform films of cells (Fig. 1E) and a significantly lower lacunarity score compared to 
WT (Fig. 1F). Consistent with this observation, the ∆cheA mutant displayed increased 
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proportional adherence as compared to WT (Fig. 1H). This indicates that chemotaxis 
plays an important role in dictating cellular organization and adhesion within H. pylori 
biofilms. 
 
Chemotactic responses to AI-2 require two novel periplasmic AI-2 binding proteins 
Because LuxS functions as both a quorum signal synthase and a metabolic 
enzyme (50), the biofilm defects of the ∆luxS could be due to additional cellular 
phenotypes other than loss of AI-2 chemorepulsion. To better test our hypothesis that 
biofilm organization is modulated by AI-2-induced chemorepulsion, we sought to 
identify the proteins specifically involved in AI-2 chemorepulsion in H. pylori. In E. coli, 
AI-2 chemotaxis requires the chemoreceptor Tsr and the periplasmic binding protein 
LsrB (42). We have previously shown that in H. pylori, AI-2 chemorepulsion requires the 
chemoreceptor TlpB (20), however there is no homolog of LsrB in H. pylori as 
determined by BLAST protein sequence alignment (51). Chemoreceptors signal via 
direct ligand binding or through interactions with ligand binding proteins that transduces 
signals to the chemoreceptor (52). Given the lack of a LsrB homolog in H. pylori, we 
assessed whether TlpB could bind AI-2 directly. We adapted an in vitro AI-2 binding 
assay (53, 54) in which AI-2 was incubated with either the purified periplasmic portion of 
TlpB or purified LsrB protein as a positive control. To quantify AI-2 binding, proteins 
were purified away from unbound AI-2, denatured to release bound AI-2, and the 
supernatant was used to stimulate V. harveyi luminescence. As expected, the 
luminescence levels induced by the LsrB supernatant were high, indicating the presence 
of bound AI-2 (Fig. 2B). By contrast, the luminescence levels stimulated by TlpB were 
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not above background levels. This suggests that TlpB does not bind AI-2 directly in vitro 
and may require additional proteins. 
 We hypothesized that a periplasmic binding protein (PBP) in H. pylori performs a 
similar function as LsrB. We identified five hypothetical proteins in G27 that were 
homologous to other periplasmic transport and binding proteins: HPG27_277, 
HPG27_431, HPG27_889, HPG27_1116, and HPG27_1197. We tested these potential 
candidates for their requirement in AI-2 chemorepulsion by making non-polar deletions 
of each PBP individually via allelic exchange and assessed the ability of these mutants to 
respond to AI-2. We tested the chemorepellant responses of these mutants to 100 μM AI-
2 using a previously described barrier assay (20). In this assay, formation of a barrier of 
swimming cells away from the source of the chemical indicates a repellent response. We 
discovered that two of the five PBP mutants, ΔHPG27_277 and ΔHPG27_431, could 
form barriers to another known chemorepellant, HCl, but formed no barrier in response to 
AI-2 (Fig. 2A). These results suggest that both of these putative PBPs are independently 
required for AI-2 chemotaxis. The other three PBP mutants remained responsive to AI-2 
(data not shown).  
Using the in vitro AI-2 binding assay described above, we tested the ability of 
these two proteins to bind AI-2. For this assay we constructed HPG27_277 and 
HPG27_431 variants lacking their hydrophobic periplasmic targeting sequences for ease 
of purification. We observed significant AI-2 binding capacity for both HPG27_277 and 
HPG27_431 proteins, similar to the LsrB positive control (Fig. 2B). These results 
indicate that both HPG27_277 and HPG27_431 bind AI-2 directly in vitro and 
independently of one another. Due to this identified function, HPG27_277 and 
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HPG27_431 will be called AibA and AibB, respectively, for AI-2 Binding proteins A 
and B. 
 
 
Figure 2: AI-2 chemotaxis requires two periplasmic binding proteins, AibA 
and AibB, that bind AI-2 independently. (A) Chemotaxis response of wild type, 
ΔHPG27_277 (ΔaibA) and ΔHPG27_431 (ΔaibB) mutant H. pylori to Brucella broth 
(BB10), 100 mM HCl and 100 μM synthetic DPD (AI-2). Shown are representative wet 
mount images of bacterial cells (white dots). Formation of a barrier (indicated in white 
arrows) indicates a chemorepellant response. Scale bar is 200 μm. (B) In vitro AI-2 
binding assay with purified proteins using a V. harveyi bioluminescence readout. Percent 
relative luminescence units are normalized to an AI-2 positive control in each 
independent experiment. Error bars represent the standard error of the mean between 
experiments. Daggers indicate a significant difference (p <0.05) from the no buffer 
negative control using a Student’s T-test. 
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TlpB, AibA and AibB are necessary for biofilm organization 
To further test the hypothesis that AI-2 chemotaxis influences spatial organization 
of cells within biofilms, we observed biofilms of strains lacking AI-2 chemoreception 
(ΔtlpB, or the PBPs ΔaibA or ΔaibB, or the double ΔaibA;ΔaibB mutant) grown on glass 
slides, as previously described  (Fig. 3A-G). We found that the cellular organization of all 
three AI-2 chemotaxis deficient strains (Fig. 3A,C,E,G) recapitulated the biofilm 
structures of the ΔluxS and the ΔcheA deficient H. pylori strains. Consistent with this 
observation, the lacunarity scores for the biofilms of these strains were significantly 
lower than WT (Fig. 3H), and similar to scores observed with ΔluxS and ΔcheA strains 
(compare to Fig. 1F). We also quantified the proportion of adherent and planktonic cells 
within 48-hour biofilms of ∆tlpB, ∆aibA, ∆aibB, and ΔaibA;ΔaibB strains grown on glass 
frit and found that the AI-2 chemotaxis deficient strains had significantly increased 
proportional adherence in biofilms compared to WT (Fig. 3I) and similar to the ΔluxS and 
ΔcheA strains (compare to Fig. 1H).  
We next attempted to complement these biofilm defects in the AI-2 chemotaxis 
deficient strains. Genetic complementation in H. pylori is limited by the precision with 
which genes can be expressed from heterologous loci. To complement TlpB, we made 
use of an engineered mutation (TlpBD114N, (55)) in the endogenous locus that we have 
shown disrupts acid sensing but not AI-2 chemorepulsion. We found that this variant of 
TlpB was able to restore normal proportion of adhesion in the biofilm (Fig. 3I), but it did 
not rescue the cellular organization phenotype (Fig. 3B) or the lacunarity of the biofilms 
(Fig. 3H). Complementation of aibA deficiency was achieved by inserting the wild type 
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 Figure 3: Chemorepulsion from AI-2 is necessary for biofilm organization. 
(A-G) Epifluorescence images of AI-2 chemotaxis defective mutants and complemented 
strain biofilms grown on glass slides for 5 days. Cells were fixed and stained with DAPI 
(white). (H) Lacunarity scores for biofilm images. Each point represents the lacunarity 
score of a single epifluorescence biofilm image post thresholding, with corresponding 
mean and standard deviation. (I) Effect of AI-2 chemotaxis disruption on adherence of 
cells in biofilms on glass frit after five days, as quantified by the crystal violet assay. 
Error bars represent the standard error of the mean for a minimum of three experiments 
for each strain. Daggers indicate a significant difference (p<0.05) from wild type using a 
Student’s T-test (H) or a one-way analysis of variance (I). 
 
aibA gene at the rdx locus (aibA*). Due to aibA being part of a potential operon, we 
engineered the putative aibB promoter into the rdx locus to drive expression of aibA. As 
with TlpB, complementation of aibA did restore proportional adhesion in the biofilm 
(Fig. 3I), but was unable to rescue the ΔaibA mutant spatial organization (Fig. 3D,H). 
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Complementation of ΔaibB was also achieved by restoration of the wild type gene and 
putative promoter at the rdx locus (aibB*). In this case, complementation restored the 
normal proportional adhesion (Fig. 3I) and was able to rescue the spatial organization of 
cells in the biofilm back to the WT spatial patterning (Fig. 3F), with a slightly higher 
lacunarity score than WT (Fig. 3H; p=0.04 by Student’s T-test).  
We hypothesized that the partial rescue in lacunarity observed in the aibA* and 
tlpBD114N strains may be due to decreased transcript or protein levels compared to WT. To 
address this, we used qRT-PCR to quantify the relative amount of aibA, aibB and tlpB 
transcripts in the complemented strains compared to WT (Fig. A3; see the appendix for 
all figures with an “A” designation). We observed that the levels of aibB in the aibB* 
strain was roughly WT levels (Fig. A3, WTaibB and aibB*), and indeed we observe full 
rescue of biofilm phenotypes with this strain (Fig. 3F,H,I). The levels of aibA in the 
aibA* strain were approximately 60% of levels of aibA in WT (Fig. A3, WTaibA and 
aibA*). This may explain why we observed incomplete rescue of the spatial organization 
and lacunarity of aibA* biofilms (Fig. 3D,H). We observed that the tlpBD114N complement 
has similar levels of tlpB transcript as in WT (Fig. A3, WTtlpB and tlpBD114N), consistent 
with WT levels of protein expression in this strain (55). However, this study also showed 
that the TlpBD114N protein is less stable than the WT TlpB protein in vitro, which could 
explain the incomplete rescue of the tlpBD114N biofilm spatial organization and lacunarity 
(Fig. 3B,H). 
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AI-2 is sufficient to alter biofilm organization during biofilm formation in a chemotaxis 
dependent manner 
Having demonstrated that AI-2 production and chemotaxis are necessary for 
normal biofilm formation, we next wanted to extend our findings by manipulating the 
system with exogenously added AI-2. To accomplish this, we added AI-2 at the time of 
inoculation of cells into wells containing glass frit and quantified the difference in 
percent adherence (Fig. 4A). We determined empirically that 37nM AI-2, a concentration 
within the range produced by H. pylori endogenously (56), caused the greatest effect in 
these assays, and we used this concentration in all subsequent experiments. We found 
that exogenous AI-2 reduced the proportion of adhered WT H. pylori when measured 48 
hours after initiation of biofilm formation and AI-2 addition. We also observed a 
significant reduction in adherence for the ∆luxS strain upon addition of AI-2. This is 
consistent with the fact that although the luxS deficient strain is unable to produce AI-2, it 
can still respond to exogenous AI-2 (56). Next we performed this experiment with the 
AI-2 chemotaxis deficient strains ∆cheA, ∆tlpB, ∆aibA, and ∆aibB. Consistent with the 
inability of these strains to sense AI-2, they exhibited no differences in the proportion of 
adherent cells in the presence or absence of exogenous AI-2. These results indicate that 
biofilm organizational patterning induced by AI-2 requires intact AI-2 sensing and that 
AI-2 is sufficient to decrease adherence in biofilms during the early stages of biofilm 
formation. 
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 Figure 4: Chemorepulsion from AI-2 is sufficient to decrease adherence in 
biofilms. (A) Change in adherence of strains in biofilm with addition of exogenous AI-2 
(37 nM) at time of inoculation. Daggers indicate a significant difference (p<0.05) from 0 
(no change) using Student’s T-test. (B) Fraction change in biofilm size (grey bars) and 
number of planktonic cells (white bars) measured 72 hours after the initiation of the 
biofilms and 24 hours after replacement of media containing 37 nM exogenous AI-2. 
Daggers indicate significant difference (p<0.05) from 1 (no change) using a Student’s T-
test. Box plots show the mean and standard deviation for a minimum of three 
experiments for each strain. 
 
We next tested directly whether AI-2 chemotaxis acted to decrease adherence in 
biofilms by promoting dispersal from mature biofilms. We grew biofilms of WT and 
∆luxS for 48 hours, gently removed the media containing planktonic cells, and replaced it 
with fresh media either with or without exogenous AI-2 (37 nM). At this time point, 
adherent cells were readily visible on the sides of the well and on the glass frit. After 
another 24-hour incubation, we quantified the populations of planktonic and adherent 
cells. Because we removed planktonic cells from the wells at 48 hours, we assumed that 
all cells entering the planktonic population after media replacement were ones that 
dispersed from the pre-existing biofilm. We calculated the change in the biofilm 
(adherent) population between cultures treated with AI-2 versus untreated controls and 
separately calculated the change in the planktonic (non-adherent) population between the 
two treatment groups (Fig. 4B). Both WT and ∆luxS strains exhibited a decrease in their 
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biofilm populations upon AI-2 addition, suggesting that AI-2 was sufficient to have 
triggered partial biofilm dispersal. Reciprocally, there was an increase in the number of 
the planktonic cells of these two strains upon addition of AI-2. To confirm the role of 
chemotaxis in AI-2-mediated biofilm dispersal, we examined the response of the ∆cheA, 
∆tlpB, ∆aibA, and ∆aibB mutant biofilms to AI-2 addition. We found no significant 
difference in the biofilm or the planktonic populations of any of these strains upon the 
addition of AI-2. These results indicate that AI-2 promotes dispersal of cells from pre-
existing biofilms by a chemotaxis dependent mechanism. 
 
Abolishing AI-2 production or AI-2 chemotaxis results in larger microcolony formation 
on cultured epithelial cells 
We wanted to test whether this AI-2 chemotaxis response was relevant to the 
fitness of H. pylori on epithelial cells where they will experience a different set of 
chemical signals than on abiotic surfaces. To do this, we adapted a previously described 
microcolony assay (18) using polarized Madin-Darby Canine Kidney (MDCK) epithelial 
cells seeded onto a transwell filter. We used the G27MA strain, which had been adapted 
to grow well on MDCK cells (57), in contrast to the parental G27 strain that does not 
grow well in this assay (data not shown). We infected MDCK monolayers with WT 
G27MA and isogenic ∆luxS, ∆cheW (a functionally similar mutant to ΔcheA), ∆tlpB, 
ΔcheA, ΔaibA, and ΔaibB strains to test if AI-2 production or chemotaxis influenced the 
size of microcolonies formed. The attached bacteria grow on the epithelial cells and form 
aggregates or microcolonies. We hypothesized that similar to what we observed in the in 
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vitro biofilm formation, that we would expect increased dispersal of cells from 
microcolonies in an AI-2 chemotaxis dependent manner.  
To do this, we fixed and stained the transwells to visualize H. pylori cells and 
MDCK cell junctions at 5 minutes post infection (initial attachment) and at 3 days post 
infection (Fig. 5A-C). To determine if all strains had equivalent growth and attachment 
on the MDCK cells, we estimated the attached bacteria on the cell layer at 5 minutes and 
3 days post infection. To do this, we quantified the average microcolony sizes of cells in 
at least 3 fields of triplicate transwells for each condition and used the size measurement 
of a single H. pylori cell (20 pixels) to estimate the number of H. pylori cells in the 
image. We then extrapolated this to estimate the number of attached H. pylori cells in the 
entire transwell (Fig. 5D). We observed that the WT, ∆luxS, and ∆tlpB strains had 
significantly increased numbers of attached bacteria from 5 minutes to 3 days post 
infection. However, for ∆cheW, ∆cheA, ∆aibA, and ∆aibB strains, we observed no 
significant increase in attached bacteria over the course of the experiment. There are 
several possible explanations for this observation, including lack of growth on the 
MDCK cells, defects in attachment, or increased dispersal of cells from microcolonies. 
Given the ambiguity of these strains in this assay, we were unable to interpret and 
evaluate these strains using this assay.  
For the WT, ∆luxS and ∆tlpB strains that were able to grow equivalently in this 
assay, we measured the average microcolony size from 5 minutes to 3 days post infection 
(Fig. 5E). We found that the ∆luxS strain had a significant increase in microcolony size at 
3 days post infection compared to WT, while there was no significant difference in initial 
attachment (Fig. 5E). Thus, disruption of luxS results in increased aggregation, which is 
  
 
23
 
Figure 5: Disruption of either AI-2 production or AI-2 chemotaxis results in 
larger microcolonies on cultured epithelial cell monolayers. (A-C) Representative 
images of WT, ΔluxS, ΔcheW, and ΔtlpB H. pylori microcolonies on polarized MDCK 
monolayers at 3 days post-infection. H. pylori cells are visualized in red, nuclei in blue, 
and cell junctions in green. Scale bar is 10μm. (D) Estimated number of attached bacteria 
on MDCK epithelial cell layer at 5 minutes and 3 days post infection for all strains. Each 
point represents the estimated number of bacteria averaged over multiple images per 
transwell. Error bars represent the standard error of the mean. Daggers represent 
statistical significant increase in number of attached bacteria from 5 minute to 3 day 
attachment for each strain. (E) Plot of microcolony area, in units of pixels, for each strain 
at 5 minutes and 3 days post inoculation. Each dot represents the average size of all the 
colonies in an image, in pixels. Three images were taken per transwell, with three 
replicate transwells per experiment. Error bars represent standard error of the mean. 
Daggers represent statistical significance of pixel sizes (p<0.05) from WT through a one-
way analysis of variance.  
 
consistent with our observations in the in vitro biofilm assays (Fig. 1H). Also consistent 
with our predictions, we observed that the lack of tlpB resulted in microcolony sizes 
significantly larger than WT and similar to the ∆luxS strain (Fig. 5E). Taken together, 
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these results suggest that AI-2 chemorepulsion is important for promoting H. pylori 
dispersal from cell aggregates on epithelial cell surfaces.  
Discussion 
For many bacterial species, quorum sensing has been well characterized to 
influence biofilm formation through the regulation of gene expression. Here we introduce 
a new role for quorum sensing in shaping biofilms on a much more rapid time scale 
through chemotactic responses of cells to quorum signals. We provide evidence that H. 
pylori biofilm dispersal and cellular spatial organization is shaped by chemorepulsive 
responses to AI-2 in H. pylori. 
 
H. pylori uses a novel AI-2 sensing mechanism 
Although many bacterial species produce and sense AI-2, mechanisms for AI-2 
sensing are not strictly conserved among them. Prior to this work, two examples had been 
described for AI-2 sensing: one through the periplasmic LuxP binding partner of the 
LuxQ histidine kinase in Vibrio species, and a second through the PBP LsrB in several 
phylogenetically distinct families, which serves as both an AI-2 transport protein and 
binding partner for the chemoreceptor Tsr (53, 58, 59). In this study, we investigated the 
molecular basis for AI-2 chemoreception in H. pylori and discovered two PBPs, AibA 
and AibB, that are both independently required for AI-2 perception. AibA and AibB are 
conserved at greater than 95% identity at the amino acid sequence level throughout H. 
pylori species. Protein sequence homology identifies AibA as homologous to dipeptide 
binding proteins (39% identity with E. coli dipeptide binding protein, Protein Data Bank 
ID 1DPP) and AibB as homologous to molybdate binding proteins (36% identity to 
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Azotobacter vinelandii periplasmic molybdate-binding protein, Protein Data Bank ID 
1ATG). However, to our knowledge this study is the first to demonstrate a function of 
these proteins. Despite the shared function of AI-2 binding, AibA, AibB, LsrB and LuxP 
show little conservation in amino acid sequence (Fig. A4). We predict that other bacteria 
may also have chemotactic responses to AI-2 that have not yet been identified due to the 
lack of sequence homology among AI-2 binding proteins.  
The requirement of two PBPs for AI-2 perception is novel for chemotransduction 
and uncommon in signal transduction in general. In Pseudomonas aeruginosa, the 
FpvCDEF system for iron uptake requires two PBPs, FpvC and FpvF. However, in this 
system, a FpvC/FpvF complex is required for binding to ferric compounds (60). In 
contrast, AibA and AibB both bind AI-2 independently in vitro (Fig. 2B). We do not yet 
know if AibA and AibB form a complex in the cell and if so, in what stoichiometries, but 
this is a possible model for the chemorepellant response in H. pylori that we plan to 
explore in future work. 
 
Responses to AI-2 on different time scales promote biofilm dispersal 
Cell dispersal from biofilms is an important part of the life cycle of these 
structures. Although cells in biofilms benefit from protection from environmental 
stressors, a sedentary lifestyle is not always advantageous. It may be beneficial for cells 
to leave the biofilm if there are abundant external resources available or if resources are 
depleted at the biofilm site. The dispersal of cells from biofilms in response to chemical 
cues can be described as “bet hedging”, which is an evolutionary response to changes in 
environments (61). When the chemical cue driving dispersal is endogenously produced 
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and proportional to cell density, this provides a mechanism to maximize the ability of a 
population to explore new habitats and avoid depleting resources at the original site.  
Cells can promote their dispersal from biofilms via several mechanisms that 
involve processes over different time scales. A common mechanism for dispersal 
involves the down regulation of matrix producing proteins and the up regulation of 
enzymes (proteases, DNases, etc.) to degrade extracellular polymeric substances and 
nucleic acids that form the adherent matrix between cells of the biofilm (62, 63). Several 
bacterial species upregulate motility-associated genes, such as those required for flagellar 
biosynthesis, at the onset of dispersal (63). However, these mechanisms require changes 
in gene expression that take place over a time scale of minutes to hours. A mechanism for 
more rapid dispersal from biofilms is known as seeding dispersal, which has been shown 
to contribute to the virulence of several bacterial pathogens. Biofilms of Pseudomonas 
aeruginosa, Staphylococcus aureus and others (63) form hollow cavities containing non-
adherent, motile cells. Upon weakening of the extracellular matrix, these planktonic cells 
exit the biofilm in large numbers. Our work showing that chemotactic responses, which 
occur on the timescale of seconds to minutes, also provides a rapid mechanism for 
bacteria to exit a biofilm. We speculate that this would allow the structure to be much 
more plastic and adaptable to rapid fluctuations in the external or internal environment of 
the biofilm. It is likely that cells use multiple mechanisms of dispersal to orchestrate their 
exit from the biofilm when it is most advantageous to do so.  
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The spatial patterning of chemical cues can influence biofilm formation 
H. pylori cells encounter a diversity of host and microbial derived signals in their 
native environment of the human stomach, the integration of which will determine their 
spatial distribution. Our experiments demonstrate that AI-2 chemotactic responses are 
necessary and sufficient for modulating H. pylori biofilm formation. We observed similar 
requirements for AI-2 production and reception for biofilms grown on glass frit or for 
microcolonies grown on epithelial cells. However, we noted that the majority of 
chemotaxis deficient strains were less able to attach or grow well on the MDCK cells. 
Previous work has shown that H. pylori uses chemotaxis as a guide to interact with the 
mouse stomach epithelium (64). In our system, we hypothesize that epithelial cells 
provide H. pylori more attractive cues than glass frit, and thus chemoattraction would 
play a more important role in the seeding of microcolonies on the epithelial surface than 
in the glass frit biofilm assay. Thus, in the case of growth on epithelial cells, the loss of 
chemotaxis would eliminate both attractive and repulsive drivers of microcolony 
formation, whereas on the glass frit only repulsive responses would be lost. This may 
explain the differences in attachment of the chemotaxis mutants on the abiotic versus 
biotic surfaces.  
Our results also provide insights into the spatial patterning of AI-2 during biofilm 
formation. We observed that adding exogenous AI-2 to a wild type and ∆luxS culture was 
sufficient to decrease the proportion of adherent cells in biofilms, however this 
exogenous AI-2 addition to the ∆luxS culture could not fully restore proportional 
adherence back to wild type levels. We assume that the bulk addition of AI-2 at a single 
time point does not accurately recapitulate the concentrations and spatial distributions of 
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endogenously produced AI-2 experienced by cells in the growing biofilm. Indeed, we 
observed stronger effects on biofilm structures by genetically manipulating the cells to 
overproduce AI-2 than when we added the chemical exogenously. We predict that small 
or stochastic changes in the AI-2 environment during biofilm growth can alter the overall 
structure of the biofilm as it grows. 
A striking effect of the loss of AI-2 production or sensing is the more 
homogenous spatial organization of the biofilms grown on glass, which appear to be 
uniformly dispersed throughout the biofilm, rather than heterogeneous clumps 
interspersed with sparse areas. We hypothesize that local fluctuations in AI-2 
concentrations are important determinants of the spatial heterogeneities that are 
characteristic of wild type H. pylori biofilms. One could even imagine a positive 
feedback loop in which stochastic fluctuations in AI-2 concentration would give rise to 
different local dispersal frequencies, creating heterogeneities in cell density that would 
enhance local variations in AI-2 concentrations. Interestingly, previous studies have 
shown that luxS expression in sessile biofilm populations is high for the first two days, 
but decreases significantly in the biofilm cells after this time point (65, 66). Such a down-
regulation of luxS could mark a transition to a more mature biofilm stage with less cell 
dispersal. The spatial heterogeneities observed in our wild type H. pylori biofilms 
resemble those described in other biofilm systems to be critical for nutrient and waste 
product flux and the overall fitness of the organisms within the biofilm structure (40). We 
speculate that because AI-2 chemorepulsion can operate on a rapid timescale and is 
sensitive to subtle spatial and temporal fluctuation in AI-2 concentration, it serves as an 
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important mechanism for generating the spatially heterogenous distribution of cells in a 
mature biofilm. 
 
Chemotactic responses to quorum sensing molecules as determinants of multi-species 
biofilm organization 
The dynamics of biofilm formation and maturation require complex, sequential 
mechanisms that give rise to an architectural structure that allows for protection from 
environmental stressors, adequate nutrient and waste flow, and contact for bacteria with 
other cells and their host (67). We have shown for monospecies H. pylori biofilm 
formation, chemorepulsion from AI-2 is a determinant of spatial organization and 
dispersal. Given that AI-2 is an important inter-species signaling molecule, we 
hypothesize that it may play an important role in mixed species biofilm formation as 
well.  
In addition to H. pylori, E. coli has also been shown to exhibit chemoresponses to 
AI-2, in this case sensing the quorum signal as a chemoattractant (42). Interestingly, 
biofilms of a ∆luxS strain of E. coli were found to be thinner and less dense than their 
wild-type counterparts (68), consistent with the absence of a self-produced attractant. 
Furthermore, the same study showed the addition of exogenous AI-2 to ∆luxS E. coli 
biofilms resulted in a partial but significant rescue of biofilm biomass, similar to the 
partial rescue we observe upon AI-2 addition to ∆luxS H. pylori. This suggests that AI-2 
may influence spatial organization and adhesion in E. coli biofilms in an analogous but 
opposite way as in H. pylori biofilms. E. coli’s ecological strategy may be to use AI-2 to 
locate and persist in the densely colonized colon, whereas H. pylori may use AI-2 to 
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promote dispersal out of individual gastric glands where concentrations of AI-2 are likely 
to be high. Similar to our observations with H. pylori, a luxS mutant of Vibrio cholera is 
reported to develop more adherent biofilms (69), implying a possible chemorepulsion 
response to AI-2.  
Given that nearly all biofilms in nature are comprised of many organisms (25), it 
is interesting to speculate how collective AI-2 production and individual AI-2 perception 
could organize biofilm structures. High AI-2 producers would serve as foci for those 
species attracted to AI-2 whereas AI-2 consumers could create permissive 
microenvironments for organisms averse to high AI-2 concentrations, with organisms of 
similar AI-2 preferences becoming segregated in the process. More generally, differential 
chemoresponses to bacterial-produced chemicals could be strong drivers of multispecies 
biofilm organization, layered upon the existing chemical landscape of the pre-colonized 
environment, be it a host tissue or an abiotic surface.  
If AI-2 is a common chemotactic cue among bacteria, this knowledge could be 
harnessed for treatment of human infections. A recent report showed that AI-2 production 
by a colonic commensal, Ruminococcus obeum, can promote the resolution of Vibrio 
cholera infection in a gnotobiotic mouse model, through an unknown mechanism (70). 
We speculate that high AI-2 producing commensals may serve as sources of repulsive 
cues that drive Vibrio cholera from the intestine. In the case of H. pylori, broad spread 
inflammation of gastric tissue throughout the organ is correlated with increased gastric 
cancer risk (4), presumably due to broader distribution of H. pylori in the stomach. It may 
be possible to manage the spread of H. pylori infection by inhibiting the AI-2 chemotaxis 
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pathway to prevent dispersal of the cells to other areas of the stomach, thus reducing the 
risk for more severe disease. 
 
Methods 
H. pylori strains and bacterial culture  
H. pylori strain G27 was the primary strain used in this study (71), and it was the wild-
type strain from which isogenic mutants were derived. Mutant strains were selected using 
the appropriate antibiotic media and verified by PCR genotyping. Genetic 
complementation of disrupted genes was achieved by inserting the full coding region plus 
predicted promoter sequence of the disrupted gene into the rdxA locus (72). The tlpB 
complemention strain replaced the wild type gene at the endogenous locus with a point 
mutant (tlpBD114N) (55) that retains AI-2 chemotaxis but is acid chemotaxis deficient. The 
aibA complemention strain (aibA*) replaced the wild type gene at the endogenous locus 
with a copy of the aibA gene at the rdxA locus. Due to aibA being in a potential operon, 
the aibB promoter was inserted upstream of the aibA gene.  The aibB complementation 
strain (aibB*) replaced the wild type gene at the endogenous locus with a copy of the 
aibB gene with native putative promoter at the rdxA locus. The luxS overproducer strain 
(luxSOP) was constructed by inserting an additional copy of luxS into the rdxA locus. 
Strains were grown on BBL Columbia Agar (BD) plates supplemented with 5% 
defibrinated horse blood, vancomycin (10 μg/μl), amphotericin B (8 μg/ml), and beta 
cyclodextrin (0.2% w/v) or in liquid Brucella Broth containing 10% fetal bovine serum 
(BB10) media in standard conditions, as previously described (56). 
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The H. pylori strain G27MA was used (57) for the microcolony experiments in Figure 5 
due to poor colonization by G27 on MDCK cell epithelia. ΔcheW, ΔluxS, ΔtlpB, ΔcheA, 
ΔaibA,and ΔaibB mutants in G27MA were constructed by deletion of the cheW, luxS, and 
tlpB, cheA, aibA, and aibB coding DNA sequence, respectively, using a PCR based 
method as previously described (73). The coding DNA sequence of cheW, luxS, cheA, 
aibA and aibB were replaced with the aphA gene (conferring kanamycin resistance). The 
coding DNA sequence of tlpB was replaced with the cat gene (conferring 
chloramphenicol resistance). Mutants were selected on the appropriate antibiotic media 
and verified by PCR. 
 
Biofilm imaging  
H. pylori cultures were grown in BB10 broth, shaking in microaerobic conditions at 37°C 
until an OD600 of 0.6-0.9. The cultures were diluted back to 1x107 cells ml-1. 100 μl of 
culture was placed onto a clean glass slide (22mm x 22mm) and allowed to incubate in a 
humidified chamber for 5 days at 37OC, 10% CO2 at which point a thick biofilm was 
readily visible on the air-liquid interface over the surface of the drop. The slides were 
carefully removed from the incubator and placed onto a 55OC heating block to gently 
evaporate the media, allowing the biofilm to settle onto the glass slide. The biofilm was 
fixed with 4% PFA in 1x PBS for 15 minutes, then washed 3 times with 1x PBS. To 
visualize, one drop of Vectashield hard set with DAPI (Vector Labs) was added to the 
biofilm and covered with a coverslip. Biofilms were imaged with a 10x lens on a Nikon 
Eclipse TE2000-U microscope. 
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Frac-Lac analysis of biofilm images  
For each slide, a minimum of three images were taken across the entirety of the biofilm. 
The contrast of the biofilm images was altered in Matlab using the built-in function 
adapthisteq.m (contrast-limited adaptive histogram equilization- CLAHE) with a 
ClipLimit parameter of 0.05. The altered images were thresholded using Otsu’s method 
(example in Fig. A2A’,B’). The resulting binary images were run through the FracLac 
plug-in in ImageJ (48, 74) to determine lacunarity with a Box Count analysis of binary 
images (black background) using a block series with 12 orientation positions and block 
sizes from 0 pixels to 32% of image. Lacunarity scores were pooled by strain across a 
minimum of two experiments per strain. 
 
Biofilm adherence assay  
We used a biofilm adhesion assay previously described (44). H. pylori cultures were 
grown in BB10 to an OD600 of 0.6-0.9 and cultures were diluted back to 5x107 cells ml-1. 
1 ml cultures were added to a 12 well suspension culture plates (Olympus plastics) filled 
approximately 1/3 full with autoclaved glass frit (Bullseye Glass) to increase the surface 
area available for cell attachment. Each experiment used 3 or 4 replicate wells filled with 
the same culture of H. pylori. The culture plates were incubated stationary for 2 days at 
37°C, 10% CO2. To quantify cells in the planktonic and biofilm populations, 1 ml of 1% 
crystal violet dye was added to cultures and allowed to incubate for 15 minutes. The 
liquid was removed via careful aspiration, and cells were spun down for 3 minutes at 
13500 rpm and saved as non-adherent cells. The adherent cells that were attached to the 
sides of the well and the frit were washed three times with 1 ml of 1xPBS. Each wash 
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was added to the tube of non-adherent cells, spun down, and saved. After washes, the 
crystal violet in the cells of both the adherent and the non-adherent populations was 
extracted in 1 ml of 95% ethanol, and spun at 13500 rpm to pellet out cells. The 
absorbance of the supernatant was then measured using a spectrophotometer at OD595. 
The percent adherence of biofilm cells in the total population of the well was calculated 
as the absorbance of the adherent population divided by the sum of absorbance of both 
adherent and non-adherent cells, multiplied by 100.  
 
For experiments adding exogenous AI-2 ((S)-4,5-Dihydroxy-2,3-pentandione, DPD, 
Omm Scientific), strains were grown as above. The culture was then split into two 
subcultures, one with AI-2 added to a final concentration of 37 nM and the other treated 
with an equal volume BB10 as a control. The cultures were added to the glass frit and 
incubated for two days and analyzed as above. The fraction adherence of cultures with 
AI-2 addition was compared directly to the control, and was calculated by dividing the 
average percent adherence of the AI-2 treated cultures by the average percent adherence 
of the non-treated control.  
 
For experiments where AI-2 was added to replacement media, the strains were grown up 
as above. After 48 hours the liquid media was removed by pipette from each well. To 
wash the biofilm cells, 1 ml of BB10 was gently added to each well and removed. 1 ml of 
media, either with or without the addition of AI-2 to a final concentration of 37 nM, was 
added back to the wells and incubated for 24 hours. The crystal violet assay was used to 
quantify the proportion of cells in the biofilm separately from the proportion of cells in 
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the planktonic media. The change in biofilm size or planktonic cell number after addition 
of AI-2 was calculated by finding the difference in Abs595 of cultures with AI-2 from 
Abs595 of the BB10 control. 
 
Identification of putative periplasmic binding proteins in H. pylori G27  
Proteins annotated as being “transport and binding proteins” in H. pylori strain J99 were 
identified using The Institute for Genomic Research (TIGR). The seven proteins were 
analyzed using Basic Local Alignment Search Tool for proteins (BLASTp) for homology 
to other known periplasmic binding proteins. Of the seven, five protein candidates 
remained. The corresponding proteins and genes in H. pylori G27 were identified using 
BLASTp and were further characterized for roles in AI-2 chemotaxis. 
 
Chemotaxis response assay 
As previously described (20), H. pylori were inoculated into liquid BB10 media from 
plate and grown shaking to an OD600 of 0.7-0.9. Cultures chosen to assay had at least 60% 
of cells motile and minimal clumping. An 8 μl sample was spotted onto a glass slide and 
covered with a coverslip (22mm x 22mm). The coverslip was sealed on 3 sides with clear 
nail polish. 8 μl of treatment (BB10, 100 mM HCl in BB10, or 100 μM synthetic AI-2 in 
BB10) was added to the side of coverslip not sealed. After approximately 5-10 minutes, 
the culture was imaged at 10x through a ×40 phase filter on Leica DMIL microscope. The 
formation of a barrier indicated a response to treatment. Representative images were 
taken of the barrier, or in similar locations on the slide in conditions with no barrier 
formation.  
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Protein purification and AI-2 binding assay 
Assessment of the AI-2 binding ability of proteins were based on previous methods (53, 
54). LsrB (kindly provided by Stephen T. Miller, Swarthmore College, Swathmore, PA) 
was cloned into the pGex-4T-1 expression vector. The periplasmic portion of the tlpB 
gene (coding for TlpB residues 33-211) were cloned into a pGex-4T-1 expression vector. 
aibA and aibB genes were cloned lacking the periplasmic targeting sequence (aibA 
lacking the coding region for amino acids 1-22, aibB lacking the coding region for amino 
acids 1-24) into a pGex-6P-1 expression vector  (GE Healthcare). The plasmids were 
transformed into BL21 E. coli for protein expression. Protein purification was achieved 
using a Glutathione Sepharose 4B column (GE Healthcare) following the recommended 
protocol. The GST tag was left on the purified proteins after we determined GST alone 
did not show AI-2 binding activity (data not shown). The GST tag was cleaved from 
AibB because of apparent partial spontaneous cleavage of the GST tag during 
purification. GST cleavage was achieved after elution of AibB from the column by 
adding 1 unit of PreScission Protease enzyme and incubated overnight at 4°C as 
described (GE Healthcare). Purified proteins were dialyzed into a storage buffer of 300 
mM NaCl, 10 μM Tris (pH 8) and 5 μM 2- mercaptoethanol, concentrated with a 
VivaSpin-20 filter (GE Healthcare), and stored at -80°C. 
 
For the protein-AI-2 binding assay, all purified proteins were normalized by dilution into 
assay buffer (300 mM NaCl, 10 mM sodium phosphate pH 7) to a concentration of 6 mg 
ml-1 as quantified by NanoDrop-1000 spectrophotometer (Thermo-Fisher Scientific). 200 
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μl protein was incubated with 100 μl of 1 mM synthetic AI-2 diluted into assay buffer at 
4°C for 120 minutes. The sample was loaded onto a Sepharose G25 fine column (Sigma 
Aldrich). The column was washed with 4 x 200 μl volumes of assay buffer and the eluate 
was collected. Protein eluted was quantified by direct application of the sample to the 
Nanodrop and concentrated to 100 uL using Amicon Ultra 10K membrane centrifugal 
filter. Retentate was incubated in a 55°C water bath for 10 minutes to denature the protein 
and release any bound AI-2 into the supernatant. The sample was centrifuged at 14,000 
rpm for 2 minutes to pellet protein.  
 
The supernatant was directly used in Vibrio harveyi luminescence assay to test for AI-2 
levels as previously described (56). Briefly, an overnight culture of V. harveyi was 
diluted 1:5000 in fresh AB medium (300 mM NaCl, 50 mM MgSO4, 2% w/v casamino 
acids, 10 mM potassium phosphate pH 7, 1 mM L-arginine, 1% w/v glycerol). 90 μl of 
diluted V. harveyi culture was added to 10 μl of protein supernatant and put into a 96-well 
plate in triplicate. Levels of luminescence were measured on a SpectraMax M5e plate 
reader (Molecular Devices) each hour over the course of 6 hours with incubation on a 
shaker at 30°C in between measurements. Relative luminescence units (RLUs) for each 
sample were taken at the time point where there was the largest difference between an 
exogenous AI-2 positive control and a buffer negative control, and normalized as a 
percent of the exogenous AI-2 positive control. 
 
Cell culture 
Madin-Darby Canine Kidney II (MDCK) cells (kindly provided by W. James Nelson, 
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Stanford University, Stanford, CA) (75) were grown in DMEM (Gibco) containing 10% 
FBS (Gibco) at 37°C in a 5% CO2 atmosphere. Polarized MDCK monolayers were 
generated as previously described (18). Briefly, about a half million cells were seeded 
onto 12 mm, 0.4 μm-pore polycarbonate tissue culture inserts (Transwell filters; Corning 
Costar). One day after seeding, the apical medium was changed to DMEM and the basal 
medium was changed to DMEM + 10% FBS. For four subsequent days, the basal 
medium was replaced daily with fresh DMEM + 10% FBS while the apical medium was 
unchanged. On the fifth day post seeding, the monolayers were ready for use.  
 
H. pylori infection of polarized MDCK monolayers 
The basal media of polarized monolayers were replaced with coculture medium (DMEM 
+ 10% FBS + 10% Brucella broth). The apical surfaces of polarized monolayers were 
washed 3 times with DMEM. Then 500 µl of a bacterial culture at OD600 of 0.2 (~108 
colony forming units (CFU)/ml) was added to the apical side of the monolayer and 
allowed to infect for 5 minutes at 37°C in a 5% CO2 atmosphere. Infected monolayers 
were washed 4 times with fresh DMEM to remove non-adherent bacteria. DMEM was 
added back to the apical side of the monolayer, and the cells were kept at 37°C in a 5% 
CO2 atmosphere. Each day for 3 days, the basal medium was replaced with fresh 
coculture medium, the apical chamber was sampled for CFU, and the monolayers were 
washed 4 times with DMEM before fresh DMEM was added back.  
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Confocal immunofluorescence microscopy and antibodies 
At terminal time points, samples were fixed and processed for confocal 
immunofluorescence as previously described (76). Chicken anti-Hp G27MA (57) was 
used at 1:500 dilution and mouse anti-ZO-1 was used at 1:100. H. pylori was detected 
using a goat anti-chicken 594 secondary antibody, and ZO-1 was detected using a goat 
anti-mouse 488 secondary antibody. DAPI (Invitrogen) was also used to stain for cell 
nuclei. Samples were imaged at 40x with a Zeiss LSM 700 confocal microscope, and 
extended focus images of z-stacks were analyzed via a custom MATLAB script.  
 
Statistical analysis 
All data analysis was performed using R (77) unless otherwise specified. A value of 
p=0.05 was used as a cut off to determine significance. All experiments have a minimum 
of 3 replicates unless otherwise specified. 
 
For data analysis of biofilm lacunarity (Fig. 1F, 3H), statistical analysis was performed in 
GraphPad Prism (version 6.03 for Windows GraphPad Software, San Diego California 
USA, www.graphpad.com) by pooling lacunarity scores from individual images over 
different experiments and compared to WT using a Student’s T-test. For percent 
adherence (Fig. 1H, Fig. 3I), percent adherence values from multiple experiments were 
pooled, arcsine-square-root-transformed, and assessed with a one-way ANOVA and 
Tukey HSD test against WT. To determine significance of increased RLU (Fig. 2B), the 
percent RLU from replicate experiments were pooled and compared to the buffer 
negative control using a Student’s T-test to determine significance. For analysis of 
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change with AI-2 addition (Fig. 4A), the difference in percent adherence for each 
experiment were pooled and tested against the null hypothesis of μ=0 (no change) using a 
Student’s T-test. For analysis of fraction change with AI-2 addition to replacement media 
(Fig. 4B), the values were pooled from multiple experiments and tested against the null 
hypothesis of μ=1 (no change) using a Student’s T-test. To calculate estimated number of 
attached bacteria on MDCK cells (Fig. 5D), the images of H. pylori microcolony cells 
were quantified using MAT-LAB to measure the size of microcolonies in pixels. The 
number of cells in the microcolonies was estimated by dividing the number of pixels in 
the microcolony by 20 (the empirically determined number of pixels for a single H. 
pylori cell). The number of H. pylori cells in the field of view was extrapolated to 
estimate the number of attached H. pylori cells in the entire transwell, and was averaged 
among the triplicate fields of view taken in the same well. Significance of 3 day 
attachment from 5 day attachment was achieved by performing a student’s T-test using 
GraphPad Prism within strains. To compare average microcolony size (Fig. 5E), the 
average microcolony sizes at 3 days were pooled and compared to WT with a one-way 
analysis of variance with Tukey’s test using GraphPad Prism.  
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CHAPTER III 
INVOLVEMENT OF AIBA AND AIBB PROTEINS IN THE MECHANISM OF 
AUTOINDUCER-2 SENSING 
 
Introduction 
 
 In most chemosensory systems, the methyl-accepting chemotaxis protein (MCP) 
receptor is able to bind the ligand directly and relay the signal to the Che proteins inside 
the cell. A few systems are known that use periplasmic binding proteins (PBPs) (also 
known as ligand binding proteins) that bind chemoeffector molecules and relay the signal 
to the MCP receptors (52). The other known AI-2 chemotaxis pathway in E. coli follows 
this mechanism, with the LsrB PBP hypothetically interacting with the MCP receptor Tsr 
(42). Our observations that AibA and AibB are both able to bind AI-2 independently and 
are both necessary for AI-2 chemotaxis in H. pylori suggest a unique molecular model for 
chemotaxis. This motivated us to further explore the features of these previously 
uncharacterized proteins that contribute to the molecular mechanism of AI-2 chemotaxis. 
We modeled the structures of the AibA and AibB proteins to better understand 
their characteristics and generate hypotheses about important features of these proteins. 
To do this, we used the Iterative Threading ASSEmbly Refinement (I-TASSER) 
computer algorithm to predict tertiary structures of AibA and AibB (78). We inputted the 
amino acid sequences of AibA and AibB into the I-TASSER program, which generated a 
template model using known structures of proteins in the protein data bank using a Local 
Meta-Threading Server (LOMETS), which was further refined into a full model of 
protein structure through template fragment assembly. Comparing these generated 
models to known structures of proteins with ligands bound allowed us to make 
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predictions of putative binding pockets and residues important for ligand binding, and 
revealed interesting conserved structural features of these proteins that may suggest a 
shared protein binding partner. 
 
Predicted Models of AibA and AibB Tertiary Structures 
The AibA amino acid sequence lacking the periplasmic targeting sequence (first 
43 amino acids) was submitted to the I-TASSER server, which used 10 templates from 4 
protein sequences (Protein Data Bank (PDB) ID: 3tpaA, 3m8u, 1dpeA, and 4qfk) to 
generate template models. The top sequence was PDB 3tpA, which is a homologous 
protein called HbpA2 in Haemophilus parasuis that has approximately 40% identity at 
the amino acid sequence level. These template structural models of AibA were then 
compared to crystal structures if other homologous proteins with ligands bound to 
determine the most likely structural model and to identify putative binding pockets within 
AibA. The model of AibA generated with the highest confidence (C-score = 1.78) was 
most similar to the protein GbpA from H. parasuis (PDB: 3M8U) with 38% sequence 
identity (Figure 6). AibA is predicted to be structurally similar to many type-2 PBPs, 
which typically bind their ligand in the cleft between two globular subdomains (79). 
Consistent with this observation, there is a predicted binding pocket in AibA in a similar 
location to the binding pocket of the type-2 PBP GbpA. Using the structure of GbpA with 
ligand bound (glutathione di-sulfide), we can predict which residues in the binding 
pocket of AibA are likely to be important for AI-2 binding. We identified two serines, 
S521 and S538 that have side chains in the binding pocket that are primed for hydrogen 
bonding to a small molecule such as AI-2 (Figure 6, blue side chains). We hypothesize 
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that mutating these residues to disrupt potential interactions with ligands in the binding 
pocket would render the protein unable to bind AI-2, and would abolish the ability of H. 
pylori with these mutations to respond chemotactically to AI-2.  
 
 
Figure 6: Model of AibA tertiary structure. I-TASSER generated model of 
AibA protein, based on structural similarity to GbpA from H. parasuis (PDB: 3M8U). 
Blue side chains correspond to serine residues S521 and S538 that are predicted to be 
important for ligand (AI-2) binding. 
 
We modeled the structure of AibB in a similar way as AibA using the I-TASSER 
server. Within the top 10 templates for threading with 3 different protein sequences (PDB 
1ATG, 3CIJ, and 4KD5), the top sequence being for the ModA protein from Azotobacter 
vinelandii (36% sequence identity, PDB: 1ATG). The top model with highest confidence 
score had high structural similarity to the ModA protein from E. coli (PDB: 1WOD, 36% 
identity). The predicted structure for AibB has a high confidence score (C= 1.32), and 
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appears to be structurally similar to other type-2 PBPs (Figure 7). Overlay of the ModA 
structure with ligand bound (molybdate ion) onto the predicted structure of AibB reveals 
a putative binding site in AibB. We hypothesize that two serines, S59 and S163, are 
important for AI-2 binding in AibB given the proximity of the side chains in the putative 
binding pocket and the ability to establish hydrogen bonds to a small molecule like AI-2 
(Figure 7, blue side chains). As with our hypothesis for the resides in AibA, we predict 
that mutating these serines in AibB will disrupt AI-2 binding and render the H. pylori 
cells that harbor these mutations unable to respond to AI-2. Future work will test these 
mutations both in vitro for protein-AI-2 binding, as well as in vivo in the barrier 
chemotaxis and biofilm assays. 
 
Figure 7: Model of AibB tertiary structure. I-TASSER generated model of 
AibA protein, based on structural similarity to GbpA from E. coli (PDB: 1WOD). Blue 
side chains correspond to serine residues S59 and S163 that are predicted to be important 
for ligand (AI-2) binding. 
 
PBPs participate in many important functions in the cell. PBPs are known to 
participate in chemoreception, but also in small molecule transport through the 
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membranes and sensory transduction pathways (80). It is not uncommon for a single 
periplasmic binding protein to have multiple functions in the cell (52). PBPs have ligand-
binding sites that adapt to bind a chemically diverse array of ligands (81), which allow 
them to mediate various functions. It is not surprising that AibA and AibB share such 
high homology to proteins in other systems with different identified functions, but for 
AibA and AibB, AI-2 binding and role in chemotaxis is the first function demonstrated 
for these proteins in H. pylori. 
 
Amino Acid Sequence Alignment Reveals Conserved Peptide Sequence in AibA 
and AibB Proteins  
As previously described, AibA and AibB are both Class 2 PBPs, but belong to 
different clusters within the classes and share little sequence homology (21% sequence 
identity, Figure A4) (82). I performed an amino acid sequence alignment of AibA and 
AibB using the ClustalW2 Multiple Sequence Alignment program (Figure 8A). As 
expected, there is little sequence conservation between the two proteins, but there are 
areas with homology. The first area of homology between these proteins is within the 
first approximately 20 amino acids at the N-terminal ends of the proteins that resemble a 
periplasmic targeting sequence. A second area of homology between AibA and AibB is a 
conserved 14 amino acid region towards the C-terminal end of both proteins that 
corresponds to surface exposed predicted alpha helices in both AibA and AibB (Figure 
8B,C).  
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Figure 8: Shared features between AibA and AibB proteins. (A) ClustalW2 generated 
alignment of amino acid sequence similarity between AibA and AibB. Numbers at the 
end of each row indicate residue position number of the last residue in the row. Asterisks 
indicate positions that have a single, full conserved residue; colons indicate positions that 
have residues that have strongly similar properties; periods indicate positions that have 
residues that have weakly similar properties. Residues colored red are small, 
hydrophobic; residues colored blue are acidic; residues colored magenta are basic; 
residues colored green are hydroxyl, sulfhydryl, amine, or glycine. A conserved 14-
amino acid region at the C-terminal ends of both proteins is colored and represented in 
the modeled structures in orange for both AibA (B) and AibB (C). 
A
AibA            MNNVFVKGLFFFLLLFGSFLKASENPNAALNPSKENVSVEEQKRFGGVLVFARGADGSSM 60 
AibB            MKNTFKAFAFLIVFFSSALLAQDLKIAAAANLTRALKALVK--------EFQKEHPKDAI 52 
                *:*.*    *::::: .::*  . :  ** * ::   :: :         * :    .:: 
 
AibA            DPALVTDGESYVATGNIYDTLVQFKYGTTEIEPALATSWDISPDGLVYTFHLRKGVYFHQ 120 
AibB            S-------ISFNSSGKLYAQIIQN-----------------APFDLFIAADITRPKKLYD 88 
                .        *: ::*::*  ::*                  :* .*. : .: :   ::: 
 
AibA            TKYWNKKVEFSAKDVLFSFERQMDKAKRYYSPGAKSYKYWEGMGMSHIIKSIEALDDYTI 180 
AibB            EKITPFKEEVYAKGVLVLWS---------------------------------------- 108 
                 *    * *. **.**. :.                                         
 
AibA            RFTLNGPEAPFLANLGMDFLSILSKDYADYLEQNNKKDELAKKPVGTGPFKFFLWNKDEK 240 
AibB            ------------ENLKMDSLEILKDPKIKRIAMANPK----LAPYGKASMEVLEN----- 147 
                             ** ** *.**..   . :   * *      * *...::.:        
 
AibA            IILLKNQDYWGPKAYLDKVVVRTIPNSSTRALALRTGEIMLMTGPNLNEVEQLEKLPNIV 300 
AibB            ---LKLTPSLKSKIIYGASISQAHQFVATKNAQIGFGALSLMD-------KKDKNLSYFI 197 
                   **      .*   .  : ::    :*:   :  * : **        :: ::*. :: 
 
AibA            VDKSPGLIANWLSLNTQKKYFNNPLVRLAINHAINVDDYIKVIYEGFAQKMVNPFPPTIW 360 
AibB            IDKA----------------LYNPIEQALIITKNGANNPLAKVFKDFLFSP--------- 232 
                :**:                : **: :  *    ..:: :  :::.*  .           
 
AibA            GYNYNIKPYEYDLKKAKELLKQAGYPNGFKTTIFTTSTRNPKGAVFIQASLAKIGIDVKI 420 
AibB            --------------KARAIFKEYGYIVD-------------------------------- 246 
                              **: ::*: **  .                                 
 
AibA            EVYEWGAYLKRTGLGEHEMAFAGWMADIADPDNFLYTLWSKQAASAIPTQNGSFYKSDAF 480 
AibB            ------------------------------------------------------------ 
                                                                             
 
AibA            SDLLIKAKRVSDQKEREALYLKAQEIIHKDAPYVPLAYPYSVVPHLSKVKGYKTTGVSVN 540 
AibB            ------------------------------------------------------------ 
                                                                             
 
AibA            RFFKVYLEK 549 
AibB            --------- 
                          
B C
  
 
47
We hypothesize this exposed alpha helix may be functionally relevant in these 
proteins, given their position within the proteins as surface exposed alpha helices. Surface 
exposed alpha helices can often be important for mediating protein-protein interactions 
(83), and this conserved helix may suggest a shared binding partner for both AibA and 
AibB. One likely candidate for a shared binding partner would be the chemoreceptor 
TlpB, since all three proteins are required for AI-2 chemotaxis in H. pylori. To test this 
hypothesis, I propose to mutate residues in the predicted exposed alpha helix to change 
the charges of some of the residues in this region and test if these are necessary for AI-2 
chemotaxis. Altering the positive charged residues in these alpha helices to negative 
charged residues such as glutamic acid (AibA: K374E, K377E, K381E; AibB: K233E, 
R235E, K239E; Figure 8A in magenta) could disrupt the electrostatic interactions this 
alpha helix may have with the binding partner and result in lack of ability of H. pylori to 
respond to AI-2 chemotactically, which can be tested using the barrier or biofilm 
chemotaxis assays. 
 
Proposed Model of AibA and AibB in the Mechanism of AI-2 Chemotaxis 
The requirement of AibA, AibB, and TlpB for AI-2 chemotaxis in H. pylori is a 
unique variation of a common chemotaxis mechanism. There are many examples of 
chemotaxis mechanisms that require a PBP and a chemoreceptor to sense ligands (52, 
84). The only other known AI-2 chemotaxis mechanism is in the enteric bacteria 
Escherichia coli that perceive AI-2 as a chemoattractant (42). The PBP LsrB has known 
AI-2 binding capabilities and is hypothesized to interact with the chemoreceptor Tsr. I 
hypothesize a similar mechanism in H. pylori whereby AibA and AibB interact with 
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TlpB to promote AI-2 chemorepulsion (Figure 9). I cannot predict whether or not AibA 
and AibB physically interact; I have shown that both AibA and AibB are both required 
for AI-2 chemotaxis, which might suggest potential binding between these two proteins. 
Additionally, I have shown that two copies of aibB is not sufficient to rescue the loss of 
aibA (data not shown), which suggests that overexpression of one protein is not sufficient 
to rescue the loss of the other. This may support the hypothesis that AibA and AibB may 
be forming a heterodimer in the periplasm. However, I have also shown that both proteins 
are able to bind AI-2 independently of one another, which suggests that binding between 
AibA and AibB may not be necessary. To fully elucidate this model, interactions between 
AibA and AibB would need to be tested either with purified protein components or 
through a co-immunoprecipitation. 
                              
Figure 9: Proposed model for the mechanism of AI-2 chemotaxis in H. pylori. 
At high cell density, high amounts of AI-2 are in the environment and bind to AibA and 
AibB proteins, which may interact with the chemoreceptor TlpB to promote 
chemorepulsion. CheA and CheW proteins are denoted by A and W respectively. 
Hypothetical interaction between AibA and AibB illustrated with dotted double-headed 
arrow; hypothetical interaction between AibA or AibB with TlpB illustrated with 
question marks.  
TlpB 
AibA AibB 
W W 
A A 
chemorepulsion 
periplasm 
environment 
intracellular 
? 
high cell density/high [AI-2] 
? ? 
AI-2 
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Direct interactions between proteins in the chemosensory pathway are challenging 
to observe. For example, while both LsrB and Tsr are required for the AI-2 chemotaxis 
response in E. coli, a direct interaction has never been explicitly demonstrated. The one 
example of PBP-chemoreceptor interaction is the Maltose Binding Protein (MBP) – Tar 
chemotaxis system in E. coli (85, 86). This interaction was deemed challenging for 
biochemical analysis due to the low affinity of MBP to the Tar chemoreceptor (estimated 
at 250 μM from in vivo measurements) (87). I hypothesize that the interactions between 
AibA, AibB, and TlpB, if present, would also be low affinity, transient interactions. A 
potential benefit of having transient interactions of proteins in a chemotaxis sensory 
pathway would be to not over amplify the signal present in the environment. If proteins in 
the chemotaxis system bound each other with high affinity when ligand was present, this 
would amplify the signal to the flagellar motor and decrease the sensitivity of chemotaxis 
proteins to concentrations of chemicals in the environment. A method being used more 
frequently in the bacterial chemotaxis field for detecting these more transient interactions 
is fluorescence resonance energy transfer (FRET) and bioluminescence resonance energy 
transfer (BRET) (88). Further elucidating the critical structural features of AibA and 
AibB would pave the way for the use of these more sensitive methods for detecting 
potential interactions between AibA and AibB, and interactions with the chemoreceptor 
TlpB. 
The requirement of both AibA and AibB to sense AI-2 is unique mechanism 
within known chemotaxis pathways. To my knowledge, this is the first chemotaxis 
mechanism that requires two PBPs to sense the same ligand. This brings up the question 
as to how this unique mechanism arose in H. pylori, and what benefit this has for the 
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organism. Given the lack of sequence homology between AibA and AibB, I can conclude 
that these are functional homologs but are not paralogs. Through bioinformatics analysis, 
AibA and AibB are both highly conserved within the H. pylori species, suggesting that 
there is evolutionary selection for these proteins. The two functionally similar but 
sequence dissimilar proteins likely did not arise from a gene duplication event during H. 
pylori evolution. H. pylori is a naturally competent bacterium (89), so it is possible that 
the second gene was acquired from another organism (perhaps for the advantage of a yet 
to be determined other function) and developed the capability of AI-2 binding. There are 
examples of organisms adapting to multiple copies of functionally similar proteins (90) in 
which, over time, the proteins acquire degenerative mutations that render them unable to 
perform the function alone and require the other gene/protein, thus providing strong 
selective pressure to keep both functionally homologous proteins. AI-2 sensing has been 
shown to be important in many bacterial species (22), so a hypothesis could be that H. 
pylori adapted these proteins for use in AI-2 sensing due to a competitive advantage that 
quorum sensing and AI-2 chemotaxis have for the bacterium. The ability for cells to not 
only be able to sense population size of bacteria within their immediate vicinity, but to be 
able to respond through directed motility to areas of less population density would 
increase their access to nutrients and different habitats within their environment. 
 
Methods 
I-TASSER and Modeling of PBP structure 
DNA sequences of aibA and aibB were collected from the UCSB Genome Browser (91). 
DNA sequences were converted to amino acid sequences using the ExPASy Translate 
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Tool. These sequences were submitted to the I-TASSER server with the periplasmic 
targeting sequence removed (AibA beginning at amino acid 44, AibB beginning at amino 
acid 23). The server provided the top 5 most confident predictions for tertiary structure 
for AibA and AibB, and the models with the highest confidence score (C-score) were 
chosen as the most likely model for protein structures (AibA c-score: 1.78; AibB c-score: 
1.32). The models were imported for image generation into Pymol for Windows (Pymol 
V.1.3). 
 
Bioinformatic analysis of AibA and AibB proteins 
Amino acid sequences for AibA and AibB were analyzed for putative domains using 
NCBI BLASTp by searching within the Protein Data Bank. Sequence alignment between 
AibA and AibB was performed and analyzed using the ClustalW2 Multiple Sequence 
Alignment tool. Conservation of aibA and aibB genes was determined by using NCBI 
BLASTn and searching the genomes under the organism Helicobacter (taxid:209). 
  
  
 
52
CHAPTER IV 
DISCUSSION 
Implications of AI-2 Chemotaxis for Treatment Strategies of H. pylori Infection 
 The findings described in the previous chapters have broad implications that can 
be used for evaluating current treatment strategies, as well as developing novel treatment 
strategies in the treatment or modulation of H. pylori infection. As infection with H. 
pylori still remains an important risk factor for the development of gastric cancer, 
effective treatments are critical for prevention of disease.  
Antibiotics, which have been miracle drugs in the treatment of bacterial 
infections, are becoming less effective as the acquisition of antibiotic resistance is 
increasing. The development of new antibiotics is difficult because bacteria are able to 
evolve resistance to antibiotics due to the high selective pressure antibiotics put on them. 
Thus, there is a demand for the development of novel antimicrobial treatments that are 
less likely to promote resistance in bacteria, which is gaining increased recognition. More 
than $650 million across the National Institutes of Health (NIH) and the Biomedical 
Advanced Research and Development Authority (BARDA) has been allocated in the 
coming year to significantly expand American investments in the development of novel 
antibacterial treatments (92).  
The current treatments for H. pylori infection include proton-pump inhibitors and 
at least two antibiotics to eradicate H. pylori infection including amoxicillin, 
clarithromycin, and metronidazole. This therapy is becoming less effective due to 
increased antibiotic resistance in H. pylori. The treatment regiment of a proton-pump 
inhibitor and two antibiotics can last up to 14 days and cause unpleasant side effects. This 
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contributes to poor patient compliance, which decreases efficacy of the treatment and can 
contribute to the growing problem of antibiotic resistance (7, 93). The increase in 
clarithromycin resistance since the late 1990s is correlated with a decrease in eradication 
efficiency of H. pylori treatments: from > 90% effective to a more recent eradication 
efficiency of close to 75%  (94). To combat this, treatments are incorporating 
metronidazole more often, which was effective against clarithromycin resistant strains of 
H. pylori, but now is also becoming less effective due to an increase in metronidazole 
resistant H. pylori in many areas in the world, in some areas up to ~40% (7).  
In addition to antibiotic resistance, the effectiveness of antibiotics depends on 
many factors, including dose and exposure of cells to the molecules. Cells within 
biofilms are known in many systems, including many medically relevant bacteria, to be 
more resistant to antibiotics than planktonic cells (24, 28, 31). I tested this in H. pylori by 
growing wild type cultures in plastic wells on glass frit for 48 hours as described 
previously (Chapter II, methods), then adding varying concentration of amoxicillin from 
0 to 2.5 μg/mL. After a 24-hour incubation of cells with the antibiotic, I used the crystal 
violet assay as previously described to quantify the number of planktonic and biofilm 
cells separately (Figure 10). I observed that the number of planktonic cells decreased 
significantly in a dose dependent manner with increasing concentrations of amoxicillin. 
Conversely, the presence of amoxicillin did not change the number of biofilm cells. This 
suggests that similar to what has been observed in other systems, H. pylori cells in the 
biofilm are more resistant to antibiotic treatment than planktonic cells.  
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Figure 10: Effect of amoxicillin treatment on H. pylori biofilm and planktonic 
cell growth. Biofilm and planktonic cells were quantified 24 hours post amoxicillin 
treatment using the crystal violet assay. Error bars represent the standard error of the 
mean for triplicate treatment wells. 
 
As I have demonstrated in this work, both the proportion of cells in biofilms as 
well as the spatial organization of cells within biofilms is dependent on AI-2 chemotaxis. 
Given that cells in biofilms are less susceptible to amoxicillin treatment, I would predict 
that ΔluxS or AI-2 chemotactic deficient mutants would have increased protection from 
amoxicillin because a greater proportion of cells in the population are found in biofilms. 
One way to increase the effectiveness of an antibiotic treatment may be to induce 
dispersal of H. pylori cells out of the protective biofilms. Designing a drug to induce 
chemorepulsion and dispersal of H. pylori cells out of the biofilms would make them 
more susceptible to the antibiotic treatment and could be given concurrently with current 
treatments to improve eradication efficiency. 
It is also possible that the spatial organization of cells in biofilms may contribute 
to the effectiveness of antibiotic treatment. Cells within biofilms secrete molecules to 
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form the exopolysaccharide (EPS) matrix that help protect them from environmental 
challenges by limiting diffusion of molecules within the biofilm community (95). 
Alterations in the spatial organization of cells within the biofilm may change the structure 
of the EPS matrix, which may have beneficial or detrimental consequences for the cells 
in the biofilm by changing the permeability of antibiotic molecules through the EPS 
matrix. An alternative hypothesis to my first prediction that ΔluxS or AI-2 chemotactic 
deficient mutants may have an advantage in protection from antibiotics due to a greater 
portion of the population residing in biofilms, would be that the alterations in spatial 
organization I observed may lead to detrimental defects in EPS organization that may 
actually make the cells more susceptible to antibiotic treatment. A better understanding of 
the functional consequences of altered spatial organization and adherence observed in H. 
pylori as a result of AI-2 chemotaxis, would inform therapeutic strategies in infection 
treatment. 
One emerging target for antimicrobial therapies is targeting quorum sensing (96–
98).  This is a promising field of research, because quorum sensing is not necessary for 
the bacteria to survive; thus, there is less selective pressure for the bacteria to evolve 
resistance to the antimicrobial treatment (96). Given that quorum sensing modulating 
drugs would not eliminate the infection, they instead focus on modulating bacterial cell 
processes and behaviors to something more favorable for the host. This gives an 
opportunity for the host to either eliminate the bacteria through immune processes, or live 
with the bacteria in a way that doesn’t elicit disease by inhibiting expression of virulence 
genes by the bacteria or inhibiting biofilm formation (99, 100). 
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In the case of H. pylori infection, it may be beneficial to manage the infection 
without eradicating it. H. pylori has been identified as a pathogen due to it being a 
causative agent of stomach diseases, however infection with H. pylori has also been 
correlated with a decreased incidence of esophageal cancer in humans, and shown to have 
a protective effect from asthma in animal models (101, 102). Thus, maintaining an 
infection with H. pylori while minimizing disease risk could offer the most protection of 
the host from disease. 
The research into quorum sensing targeting anti-microbial drugs typically focuses 
on the gene regulation aspects of quorum sensing. My work would suggest that targeting 
the chemotaxis aspect of quorum sensing could also be an effective strategy for 
modulating bacterial behaviors that influence their interactions with the host. Designing a 
small molecule to modify AI-2 could prevent AI-2 signaling in H. pylori. However, given 
that AI-2 is an inter-species signaling molecule, targeting the AI-2 molecule itself could 
have more pleotropic effects since it could alter other behaviors in other bacteria. An 
alternative approach would be to modify the AI-2 binding pocket of AibA and AibB 
proteins, which would have more specificity to H. pylori. Doing so would serve to disrupt 
AI-2 binding, and could generate an AI-2 “blind” phenotype. I would predict that doing 
this would promote bacterial behaviors similar to AI-2 chemotactic null mutants, such as 
decreased in biofilm spatial heterogeneity and decreased dispersal from biofilms. 
Decreased dispersal may serve to decrease the extent of colonization throughout the 
stomach and sequester the H. pylori infection to the atrium within the gastric glands. 
Since dispersal is more correlated with severe stomach disease, the hope would be that 
minimizing dispersal would minimize the host’s risk for developing more severe disease. 
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Although future studies are necessary to fully demonstrate the influence of AI-2 
chemotaxis for H. pylori, my work has contributed to the understanding of mechanisms 
that influence the spatial organization of H. pylori within their environment. More 
broadly, I have uncovered a timescale of AI-2 signaling that is much more rapid than the 
canonical mechanism for AI-2 regulation of gene expression, which may lead to further 
elucidation of AI-2 sensing and chemotaxis in other bacteria. This will aid in future work 
in other bacterial systems that will consider chemotaxis to endogenously produced 
molecules as an important determinant in cellular behaviors that modulate the 
interactions of bacterial cells with their host and environment. 
 
Methods 
Effect of antibiotic treatment on biofilm and planktonic cells 
Cells were grown as previously described (Chapter II, Methods, Biofilm adherence 
assay) and cultured in plastic wells with glass frit for 48 hours. After 48 hours, 50 μL of 
amoxicillin (VWR International) diluted in BB10 was gently added to the wells to a final 
concentration of 0 to 2.5 μg/mL amoxicillin with triplicate wells per condition. Cultures 
were incubated for another 24 hours prior to cell quantification via crystal violet assay as 
previously described.  
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APPENDIX 
 
SUPPLEMENTAL FIGURES AND METHODS 
 
 The following figures and methods correspond to supplemental material for 
Chapter II and were chosen to be included in the appendix rather than within the main 
chapter due to the information being helpful, but not critical for evaluating the content in 
that chapter. 
 
 
 
Figure A1: Relative endogenous levels of AI-2 in H. pylori cell free 
supernatant. (A) A representative experiment observing CFUs of shaking cultures over 
time for WT and luxSOP strains. Error bars represent the standard deviation of duplicate 
cell count measurements. (B) Relative luminescence units from V. harveyi 
bioluminescence assay for cell free supernatant collected over time for WT and luxSOP 
strains. Cell free supernatant also collected from ΔluxS as a negative control. Error bars 
represent the standard deviation of duplicate luminescence measurements. Daggers 
indicate significant increase (p<0.05) of luxSOP from WT using a Student’s T-test. 
 
 
              
 Figure A2: Thresholding images for lacunarity measurement. Example 
biofilm images of WT (A) and ΔcheA (B) biofilms with corresponding thresholded 
images (A’, B’) used for lacunarity scoring (Fig. 1F, 3G). 
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 Figure A3: Relative quantification of transcript levels of aibA, aibB and tlpB 
genes. qRT-PCR analysis of cDNA from WT, mutant, and complement strains. 
Amplification of each target gene is relative to the amplification of the target gene in the 
WT strain, set to 1. Error bars represent the upper and lower range between experimental 
triplicates and averaged among biological duplicates. 
 
 
 
 Figure A4: Percent identity matrix between known AI-2 binding proteins. 
Percent identity matrix determined by ClusalW2 sequence alignment between H. pylori 
G27 AibA, AibB, Vibrio cholerae LuxP, and E. coli LsrB. Numbers indicate the level of 
similarity between pairs of proteins from 0 (no similarity) to 100 (identical). 
 
 
Methods 
 
Measuring AI-2 production in H. pylori. WT, luxSOP, and ΔluxS H. pylori cultures were 
inoculated into 3 ml BB10 from plate. Four hours after inoculation, cultures were diluted 
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back to 5x107 cells ml-1 and incubated shaking at 37°C, 10% CO2. Samples of WT and 
luxSOP were taken at 4, 8, 12, 24, 36, and 48 hours post dilution and analyzed for optical 
density and colony forming units on plate. Samples of WT, luxSOP and ΔluxS were taken 
at each time point, spun down at 13500 rpm for 3 minutes, and the cell free supernatant 
(CFS) was saved and stored at -20°C. The CFS was analyzed for AI-2 using the Vibrio 
harveyi luminescence assay. 10 μl of CFS was added to 90 μl of V. harveyi culture 
(prepared as previously described for AI-2 binding assay) with duplicate samples in a 96-
well plate. Levels of luminescence were measured on a SpectraMax M5e plate reader 
(Molecular Devices) each hour over the course of 6 hours with incubation on a shaker at 
30°C in between measurements. Relative luminescence units (RLUs) were taken at the 
time point where there was the largest difference between an exogenous DPD positive 
control and the ΔluxS negative control. 
 
cDNA synthesis. WT, ΔaibA, aibA*, ΔaibB, aibB*, ΔtlpB, and tlpBD114N strains were 
inoculated into liquid BB10 media from plate and grown shaking to an OD600 of 1. 
Cultures were spun at 4000 rpm to pellet cells, and resuspended in 700 μL TRIzol reagent 
(Life Technologies). RNA was extracted following the TRIzol sample preparation 
protocol provided by the manufacturer, and the RNA pellet was resuspended in RNase-
free water. The RNA was treated with DNase-1 (New England BioLabs) to degrade 
contaminant genomic DNA following the manufacturer’s protocol. 5 μg RNA, 50 ng/μl 
random hexamer primers and SuperScript III Reverse Transcriptase (Life Technologies) 
were used to generate cDNA following the manufacturer’s protocol. The resulting cDNA 
was treated with RNase H (Life Technologies) to degrade template RNA.  
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qRT-PCR. Synthesized cDNA was amplified using primers targeting ~100 base pair 
sequences of aibA, aibB, and tlpB genes, with ureA and ureB targets as endogenous 
controls. Primer efficiency was confirmed to be > 95% for each primer set used. qRT-
PCR reactions contained 5 μl KAPA SYBR FAST qPCR Master Mix (Kapa Biosystems), 
1 μl cDNA, 10 μM forward and reverse primers, and water to 10 μl reaction volume. 
Standard qRT-PCR reactions were performed in experimental triplicates on an Applied 
Biosystems StepOnePlus PCR machine (Life Technologies) and analyzed using StepOne 
software (version 2.2.2) to calculate relative quantity of target cDNA in mutant and 
complement strains to WT using both ureA and ureB as endogenous controls. 
 
Protein sequence alignment. Gene and protein sequence for H. pylori G27 AibA 
(HPG27_277 hbpA) and AibB (HPG27_431 modA) were acquired from the UCSC 
Microbial Genome Browser (91). Representative LuxP (Vibrio cholerae, GenBank 
KFE33015.1) and LsrB (Escherichia coli 101-1, GenBank EDX40441.1) sequences were 
aligned with AibA and AibB using the ClustalW2 multiple protein sequence alignment 
(EMBL-EBI).  
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